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Abstract
During development, the mechanisms that specify neuronal subclasses are coupled to those that determine their axonal
response to guidance cues. Pax6 is a homedomain transcription factor required for the specification of a variety of neural
precursors. After cell cycle exit, Pax6 expression is often shut down in the precursor progeny and most postmitotic neurons
no longer express detectable levels of the protein. There are however exceptions and high Pax6 protein levels are found, for
example, in postmitotic retinal ganglion cells (RGCs), dopaminergic neurons of the olfactory bulb and the limbic system in
the telencephalon. The function of Pax6 in these differentiating neurons remains mostly elusive. Here, we demonstrate that
Pax6 mediates the response of growing axons to SFRP1, a secreted molecule expressed in several Pax6-positive forebrain
territories. Forced expression of Pax6 in cultured postmitotic cortical neurons, which do not normally express Pax6, was
sufficient to increment axonal length. Growth was blocked by the addition of anti-SFRP1 antibodies, whereas exogenously
added SFRP1 increased axonal growth of Pax6-transfected neurons but not that of control or untransfected cortical
neurons. In the reverse scenario, shRNA-mediated knock-down of Pax6 in mouse retinal explants specifically abolished RGCs
axonal growth induced by SFRP1, but had no effect on RGCs differentiation and it did not modify the effect of Shh or Netrin
on axon growth. Taken together these results demonstrate that expression of Pax6 is necessary and sufficient to render
postmitotic neurons competent to respond to SFRP1. These results reveal a novel and unexpected function of Pax6 in
postmitotic neurons and situate Pax6 and SFRP1 as pair regulators of axonal connectivity.
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Introduction
The selective response of axons to elongation and guidance cues
encountered along their paths enables the precise formation of
neuronal circuits and the formation of topographic maps. During
development, mechanisms that specify neuronal subclasses are
coupled to those that specify their axonal response through the
selective expression of transcription factors.
Pax6 is a homeodomain transcription factor expressed in several
territories of the developing nervous system, mostly in the
proliferative regions containing neural precursors [1]. The vast
majority of the neural progeny of these precursors including
neurons of the dorsal cortical plate or neural stem cell (NSCs)
derived neurons, shut down Pax6 expression upon exiting the cell
cycle. Consequently, very few postmitotic populations express
Pax6. Notable examples are the retinal ganglion cells (RGCs), the
dopaminergic neurons of the olfactory bulb and certain neurons in
the basal telencephalon and midbrain [2,3,4,5]. While the role of
Pax6 in neural precursors has been widely explored, revealing a
central function in cell fate specification and cell cycle regulation
[5,6,7,8,9], less attention has been paid to its functions in
postmitotic neurons, with the major exception of a recent study
demonstrating that Pax6 is needed for the survival of dopaminer-
gic neurons in the olfactory bulb [10].
RGCs are one of the best-characterized postmitotic populations
that express Pax6 [11]. Pax6 expression in both developing and
mature RGCs is graded, with higher levels in the ventro-temporal
distal cells and lower in the proximal domains [11]. These two
differentially expressing Pax6 populations project to distinct non-
overlapping and complementary topographic regions of the
superior culliculus and lateral geniculate nucleus (LGN), which
suggests that Pax6 may contribute to control axon targeting.
Indeed, RGCs of mice overexpressing Pax6 show disrupted axonal
trajectories and abnormal bundle formation [12], whereas changes
in Pax6 expression in the RGCs correlate with axonal regener-
ation in the optic nerve of lizards and zebrafish [13]. Still, there is
no information on whether Pax6 is directly involved in the control
of axon growth and what guidance cues, if any, depend upon its
activity.
Secreted Frizzled-Related Protein 1 (SFRP1) is one of the
factors known to stimulate the directional growth of RGCs axons
in Xenopus and chick retina. This activity is independent of Wnt
signaling and modulated by extracellular matrix molecules
[14,15]. Mouse Sfrp1 is expressed in several structures of the
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retina, cornea, ciliary bodies, lens epithelium, the prospective
thalamus and the proliferative regions of the telencephalon
[14,16,17,18,19]. The SFRP1 distribution often coincides with
that of Pax6 or decorates the axonal pathways of Pax6 expressing
neurons [14,16,17,18,19], raising the possibility of a functional
relationship between the two molecules.
Here we show that expression of Pax6 in neuronal postmitotic
populations is necessary and sufficient to confer neurons with a
positive response to SFRP1. Over-expression of Pax6 rendered
cultured cortical neurons competent to respond to endogenous
and exogenous SFRP1. Conversely, knock-down of Pax6 in mouse
retinal explants abolishes RGC axonal growth induced by SFRP1
without affecting RGC differentiation or their axonal response to a
different guidance cue like sonic hedgehog (Shh) or Netrin. These
results suggest that Pax6 and SFRP1 are pair regulators of axonal
connectivity in the retina and reveal a new function of Pax6 in the
postmitotic populations.
Results
1. Pax6 induces axonal growth in postmitotic neurons
The majority of postmitotic neurons, including those derived
from telencephalic Pax6 positive precursors, such as cerebral
cortical neurons or neurons derived from cortical neural stem cells
(NSCs), do not express Pax6 [2] (Fig. S1a). To test the
consequences of Pax6 expression in postmitotic populations, we
forced its expression in neurons derived from mouse NSCs. NSCs
grown as neurospheres were nucleofected with CAG-empty vector
or CAG-Pax6, together with a CAG-GFP that allowed the
visualization of transfected cells. GFP staining demonstrated
efficient transfection by FACs cytometry (Fig. S1b) and immuno-
staining of plated cells confirmed that cells transfected with CAG-
Pax6, but not those transfected with the empty vector, had nuclear
Pax6 protein expression (Fig. S1a). Plated transfected cells were
then allowed to differentiate for 9 days to analyze their
differentiation and morphology. GFP neurons identified by b-
tubulin III expression show an advance differentiated asymmet-
rical polarized morphology, both in control and Pax6 transfected
cells (Fig. 1 c), and the longer neurite was identified as the axon by
MAP1b staining (not shown), a selective marker of the distal part
of the growing axon [24]. Overexpression of Pax6 alone was
sufficient to promote axonal extension compared to control
neurons (Fig. 1a). Quantitative analysis of b-tubulin III positive-
projections confirmed a significant increment of the axonal length
from neurons transfected with CAG-Pax6 both at 6 and 9 days of
culture (Fig. S2 and Fig. 1a, respectively). Similar results were
obtained upon quantification of MAP1b projecting axons (not
shown). The total number and extension of the additional neurites
was not affected (Figure S1c).
Several reports have shown that Pax6 over-expression induces
precursor cells to exit the cell cycle and differentiate [9,25]. To
discard the possibility that increased axonal length was a
consequence of a premature exit from cell cycle and, thus, of an
extended time of differentiation, we restricted our study to those
cells that were leaving the cell cycle at similar times. To visualize
cohorts of nascent neurons, BrdU was added on the second day of
culture and extensively washed after 12 h. Analysis of BrdU-
positive neurons on the ninth day of culture confirmed that the
axons of the Pax6 expressing population were significantly longer
than those of cells transfected with mock vector (Fig. 1b and c).
Restricting to this cohort of BrdU neurons correlated with a higher
increment in axonal length as expected from the analysis of a more
homogenous population (compared Fig. 1a and b). This
demonstrates that the effect in axonal growth is unrelated to an
early exit from the cell cycle. To strengthen this conclusion, we
over-expressed Pax6 in non-proliferating primary cortical neurons
and quantified the length of MAP1b projections, obtaining similar
results (Fig. 1d and e), although the increment of outgrowth was
less evident than that observed in NCSs, likely owing to the
heterogeneity of primary differentiating neurons. Together, these
experiments demonstrated that Pax6 expression in differentiated
neurons stimulates process elongation by a cell cycle independent
mechanism.
2. Pax6 mediates the axonal response to SFRP1
SFRP1 is expressed by the neural precursors of the ventricular
zone (VZ) of the dorsal telencephalon, which give rise to both
cortical neurons and NSCs [2]. We confirmed that neural
precursor cells cultivated in vitro also express detectable levels of
the SFRP1 protein (Fig. 2a). We therefore postulated that SFRP1
produced and secreted in the culture by undifferentiated cells was
responsible for the selective axonal growth of Pax6-transfected
neurons. Addition of antibodies against SFRP1 to the culture
media two days after NSCs transfection completely blocked Pax6-
induced axonal growth, leading to processes with a length
undistinguishable from that of control cells (Fig. 2b). This result
was specific since addition of control unrelated antibodies had no
effect (Fig. 2b). This data indicated that Pax6 stimulated the
growth of NSCs derived neurons in response to endogenous
SFRP1 produced in the in vitro culture.
To support this conclusion, we next assayed the effects of
exogenously added SFRP1 upon forced expression of Pax6 in
primary cortical neurons or neurons derived from NSCs. Purified,
recombinant SFRP1 was added to the neuronal culture after
transfection and the early axonal response was evaluated after two
or three days in cortical neurons and NSCs, respectively. Notably,
addition of exogenous SFRP1 to control neurons had no effect on
the length of their axons, but stimulated, in a dose dependent
manner, the elongation of those belonging to Pax6-positive
neurons (Fig. 2c, d and Fig. S3). Therefore, Pax6 appears to be
necessary and sufficient to confer cortical neurons with the
competence to respond to SFRP1 of exogenous or endogenous
origin.
Postmitotic RGCs express Pax6 [4] and their axons respond to
SFRP1 [14]. We therefore asked whether this response was
similarly dependent on Pax6. To this end we decided to knock-
down Pax6 using shRNA lentiviral constructs. Effective knock-
down of the Pax6 protein by the shRNA lentiviral constructs was
first evaluated in cultured mammalian CHO cells transfected with
Pax6 (See Methods and Fig. S1d). Selected constructs were
thereafter targeted to the retina of E13.5 embryos by in utero
electroporation. A CAG-GFP plasmid was co-electroporated to
visualize targeted cells and their axons. The expression of Pax6
and the fate of the targeted cells were analyzed at E19.5 in
histological sections. In retinas targeted with either control or Pax6
shRNA, the majority of GFP-positive cells were located in the
inner layers, corresponding with the normal location of RGCs
(Fig. 3a and b). Double staining with anti-Pax6 and -GFP
antibodies demonstrated strong expression of Pax6 in GFP-
positive control cells but undetectable levels in the majority of cells
electroporated with the Pax6-shRNA (Fig. 3a). Quantification of
the number of GFP and Pax6 positive cells demonstrated that the
selected shRNA resulted in efficient down-modulation of Pax6 in
the mouse retina cells (Fig. 3a, graph). No significant changes were
observed in the number of apoptotic, Caspase3-positive cells [26]
(Fig. 3a). Because Pax6 is involved in cell fate decisions and cell
cycle exit [4,9,27] we next analyzed the molecular identity of the
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2, that marks most of RGCs [28], and Brn3, which labels only a
subpopulation [29]. In control retinas, an important proportion of
GFP positive cells showed expression of Islet-1/2 and Brn3, with
the expected pattern. Down-regulation of Pax6 did not block RGC
generation but somehow favored the increase of the number of
Islet-1/2 positive cells, which was less clearly correlated with that
of Brn3 positive cells (Fig. 3b). This moderated shift in the
proportion of RGCs cells might be associated to the reported
effects in cell cycle exit [4,9,27], rather than on selective cell death,
which was invariant (Fig. 3a).
Given that shRNA-mediated knock-down of Pax6 in E13.5
retinal precursors did not interfere with RGC generation and
organization, we examined the response of Pax6 deficient RGCs to
SFRP1 [14]. Explants from E13.5 retinas electroporated ex vivo
with control shRNA or shRNA constructs targeting Pax6 were
seeded on laminin-coated coverslips, stimulated with SFRP1 and
fixed 24 h after. Staining with anti-b-tubulin III confirmed that, as
in chick and Xenopus [14], SFRP1 stimulated axonal outgrowth
and extension from control mouse retinas, increasing the
proportion of axons longer than 900 mm (Fig. 4a). Similarly,
addition of SFRP1 to control electroporated retinal explants
doubled the proportion of GFP-positive electroporated RGCs with
axons longer than 200 mm (Fig. 4b), although the average length
was appreciably shorter than that of axons from non-electropo-
rated retinas (compare Fig. 4a and 4b). Likely, this is because
Figure 1. Ectopic expression of Pax6 stimulates axonal growth in cortical neurons. NSCs were nucleofected with CAG-empty vector or
CAG-Pax6 and co-electroporated with CAG-GFP. a) The graph shows the percentage of nucleofected neurons with respect to their axonal length after
9 days of differentiation. Over-expression of Pax6 increments the axonal length compared with control neurons. b) The graph shows quantification of
the axonal length of a cohort of BrdU positive neurons. c) Nucleofected neurons were identified by the specific expression of b-tubulin III and GFP.
BrdU staining allowed us to compared neurons of similar birth dates. The effect in axonal growth is unrelated to an early exit from the cell cycle.
Arrows point to BrdU stained nuclei. Bar indicates 50 mm. d) Cortical primary neurons were also transfected with CAG-empty vector or CAG-Pax6, and
with CAG-GFP. Transfected primary axons were identified by GFP and MAP1b staining. Arrows indicate the distal part of the axon stained by MAP1b.
Bar indicates 70 mm. e) The graph shows the percentage of primary neurons with respect to their axonal length. Data are expressed as the mean 6
SD. (*) p,0.05; (**) p,0.01.
doi:10.1371/journal.pone.0031590.g001
Figure 2. SFRP1 secreted by cortical cells in vitro is responsible for the axonal growth observed in Pax6 over-expressing neurons. a)
Immunofluorescence shows expression of SFRP1 (red) in differentiating, NSCs cultured for 5 days. Cells were double labeled with anti-nestin, GFAP
and b-tubulin III. SFRP1 expression is found in the cytoplasma of Nestin-positive cells or in some with a low GFAP expression (arrowheads). No SFRP1
expression was found in cell with high GFAP levels or in b-tubulin III-positive cells. Bar represents 20 mm. b) The graphs show the percent of axons
longer than 100 mm upon Pax6 overexpression in NSCs when cultured in the presence or absence of control or anti-SFRP1 antibodies. Note that
antibody against SFRP1 blocks axonal growth stimulated by the ectopic expression of Pax6. c, d) Response to increasing concentrations of purified
recombinant SFRP1 in neurons derived from NSC c) or primary cortical neurons (d). NSCs (c) and primary neurons (d) were transfected with control
empty CAG and CAG-Pax6 vectors and stimulated with different concentrations of SFRP1.Addition of recombinant SFRP1 only stimulates the growth
and elongation of axons of neurons ectopically expressing Pax6. Data are expressed as the mean 6 SD. (*) p,0.05; (**) p,0.01; (***) p,0.001.
Number of axons per condition .50 (n=3).
doi:10.1371/journal.pone.0031590.g002
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Knock-down of Pax6 in RGCs prevented their response to SFRP1
(Fig. 4b) but did not interfere with axonal initiation because the
total number of axons per explants was not significantly different
in control and Pax6 shRNA electroporated retinas in the presence
or absence of SFRP1 (not shown). Furthermore, in non-stimulated
explants, the length of GFP positive axons was similar in both
control and Pax6 shRNA electroporated retinas (Fig. 4b). Notably,
axonal growth was restored when knock-down was attempted in
the presence of a silent mutant form of Pax6 resistant to shRNA,
excluding off-target effects of the shRNA constructs (not shown).
Furthermore, Pax6 knock-down had no effect on the response of
dorsal retinal explants to exogenously added Shh (Fig. 5a and 5b)
or Netrin1 (Fig. 5c), additional axon guidance cues known to
modify RGC axon growth [23,31,32]. These results indicated that
the expression of Pax6 in mouse RGCs prompt axon extension
Figure 3. Knock-down of Pax6 in the embryonic retina does not interfere with the generation of RGCs. Frontal cryostat sections of E19.5
retinas after electroporation at E13.5 with shRNAs constructs control and targeting Pax6 and immunostained (red) for Pax6 and Caspase 3 (a) or Islet-
1/2 and Brn3 (b) as indicated in the panels. Electroporated cells are visualized with GFP (green). The graphs show the quantification of the proportion
of the double positive cells for the indicated marker. Note that shRNA efficiently target Pax6 without inducing cell death (a) or changes in expression
of markers for postmitotic RGCs (b). Bar indicates 10 in (a) and 40 mm in (b). Data are expressed as the mean 6 SD. (*) p,0.05; (**) p,0.01. Number of
axons per condition .60 (n=3). INL, inner layer; VZ, ventricular zone.
doi:10.1371/journal.pone.0031590.g003
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response to Shh and Netrin1.
The Fz2 receptor appears to mediate the axonal response to
SFRP1 in RGCs [14]. Thus, the selective induction of the
expression of this receptor appeared as possible feasible mecha-
nism of the action of Pax6. However, equal expression of Fz2
protein was detected in the axons of RGCs electroporated with
either control or shRNAs targeting Pax6. Similarly quantitative
PCR analysis did not reveal significant differences in the mRNA
levels of Fz2 from control and Pax6 overexpressing neurospheres
or primary neurons (Fig. S4). Similarly, there were no significant
changes in the expression of other members of the Frizzled
receptor family expressed in the retina, [33], including Fz3, Fz5,
Fz6 and Fz7 (Fig. S4). We therefore consider the possibility that
Pax6 could regulate the expression of members of the family of
Unc receptors, Unc5a, Unc5b, Unc5c and Unc5d, that contain
SFRP1 binding domains [34] or that of other receptors implicated
in axonal guidance like Neuropilin1 or PlexinD1 [35]. However,
Pax6 overexpression in primary cortical cells did not induce
significant changes in the expression of any of these genes (Fig. S4),
suggesting that other factors might be involved.Hence, the
regulation of the expression any of these receptors does not
underlie the specific response to SFRP1 triggered by Pax6.
Altogether, our results demonstrate that Pax6 is necessary and
sufficient to confer postmitotic differentiating neurons with the
competence to respond to SFRP1, revealing a novel non
neurogenic function of this pleiotropic transcription factor.
Discussion
Pax6 expression is crucial for dorsal-ventral and anterior-
posterior patterning of the neural tube and controls neural
precursor proliferation and fate decisions [13,36,37]. We herein
demonstrated that expression of Pax6 in postmitotic neurons is
necessary and sufficient to provide axons with the competence to
respond to SFRP1, a secreted molecule that can control growth
Figure 4. Knock-down of Pax6 blocks SFRP1 stimulated growth of retinal axons. a) Low magnification images (a) and confocal micrographs
(b) of explants from control (a) or electroporated retinal explants (b) seeded onto laminin coated coverslip and cultured in the absence or presence of
recombinant SFRP1 as indicated in the panels. Explants in (a) were stained with b-tubulin III whereas those in (b) were co-electroporated with CAG-
GFP and shRNA control or shRNA targeting Pax6 and axons were visualized by GFP expression. Graph shows quantification of the proportion of total
axon longer than 900 (a) or 200 (b) mm. Note that knocking-down Pax6 inhibits the axonal response stimulated by SFRP1. Bar indicates 300 (a) and
150 mm (b). Data are expressed as the mean 6 SD. (*) p,0.05 comparing stimulated populations; (**) p,0.01 and (***) p,0.001 compared with
control.
doi:10.1371/journal.pone.0031590.g004
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that abrogation or activation of Pax6 expression in neuronsthat,
respectively, normally do or do not express Pax6, correlates with
the response of their axons to SFRP1. This novel activity adds up
to the very limited examples of Pax6 functions in postmitotic
neurons, namely the control of dopaminergic neuron survival via
the regulation of Crystallin aA [10]. In progenitors, other recent
studies have also pointed out non-neurogenic roles of Pax6, such
as the downregulation of the neurotrophin receptor p75
NTR [38].
Together, these studies consistently highlight alternative functions
of this pleiotropic factor.
Although much progress has been made in defining the
mechanisms directing the formation of brain circuitry, there is
still much to learn about the precise coordination between axonal
connectivity and the acquisition of neuronal identities, which,
through the selective expression of certain specific transcription
factors, specifies the interpretation of these signals. Indeed, the
reported number of such transcription factors is still limited and
needs to be expanded to obtain a truly comprehensive landscape
of the determinants of neuronal connectivity. Moreover, the
mechanisms that accurately synchronize acquisition of neuronal
subtype identity with guidance molecule expression deserve
further elucidation. Examples of this coordination are offered by
the LIM homeodomain protein control of EphA receptor and
ephrin-A ligand expression during motor neuron innervation of
limb muscle [39]. Similarly, Lhx2/9 in the dorsal spinal cord
directly regulates the expression of Rig-1 [40], a divergent member
of the Robo family, required for midline crossing of commissural
axons [41]. In the retina, expression of Zic2 in the ventro-temporal
retina determines ipsilateral identity of RGCs [42] and controls
the behavior of their axons likely by regulating the expression of
EphB1 [43], a specific guidance receptor implicated in ephrinB2-
mediated repulsion of uncrossed axons at the optic chiasm midline
[44]. However, genetic control of receptor expression is not always
an evident explanation, and there are also multiple transcription
factors shown to be critical in directing axonal trajectories by still
unknown or alternative pathways. In the cerebral cortex for
example, Ctip2, and Satb2, determine the final targets of
corticospinal motor neurons and callosal projecting neurons,
respectively [45,46,47,48,49] and recent studies report that these
two cell populations differentially respond to Sema3A, a potent
repellant of cortical axons [50]. Surprisingly, similar levels of
Sema3A receptors are found in cells expressing Satb2 or Ctip2,
and the selective response is proposed to be dependent on the
control of the receptor’s endocytic and signaling pathway [51].
In this scenario, our data provide an additional example of a
transcription factor that selectively controls the response to axon
guidance cues. Although we clearly demonstrated a relationship
between Pax6 expression and response to SFRP1 in different
neurons, we did not found an obvious mechanism to explain this
relationship. In chick and Xenopus, SFRP1 binds to Fz2 to mediate
axonal response [14]. Our experiments indicate the unlikely
involvement of the Fz2 receptor and suggest other unknown
mechanisms that we have been so far unable to decipher. There
are several possible scenarios. Other yet undefined SFRP1
receptors or co-receptors might be involved. Pax6 might also
control the expression of other molecules involved in the pathway
downstream of SFRP1 response. Alternative Pax6 may regulate
the expression of ECM molecules known to be needed to control
SFRP1 response, such as laminin and fibronectin [14]. Previous
microarray analysis of Pax6 mutants and cells over-expressing
Pax6 makes way to these possibilities and have shown regulation of
guidance molecules receptors such as the Netrin receptor Unc5h,
PlexinA2 and EphA5, signal transduction molecules of the Wnt
pathway such as Gpc3, or cell adhesion molecules such as tenascin
C or cadherin 11 [52,53]. Notably, the screening of a phage
display peptide library revealed that SFRP1 binds with high
affinity to the peptide motif L/V-VDGRW-L/V, which is present
Figure 5. Knock-down of Pax6 does not affect the response of
retinal axons to Shh or Netrin 1. a) Micrographs show confocal
images of GFP positive axons of retina explants co-electroporated with
CAG-GFP and control shRNA or shRNA targeting Pax6. Explants were
seeded onto laminin coated coverslip in the presence or absence of
recombinant Shh. Bar indicates 100 mm. b) Graph shows quantification
of the proportion of GFP positive axons longer than 100 mm in the
presence or absence of recombinant Shh. c) Graph shows quantification
of the proportion of GFP positive axons longer than 200 mm in the
presence or absence of recombinant Netrin 1. Data are expressed as the
mean 6 SD. (*) p,0.05; (**) p,0.01.
doi:10.1371/journal.pone.0031590.g005
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interact is still unknown.
Understanding the role of Pax6 and SFRP1 in the selective
connectivity of neuronal subclasses may contribute to untangle a
piece of the puzzle of brain circuits. In particular, in the retina,
developing RGCs express different levels of Pax6 protein [11] and
their axons travel in the vicinity of several anatomical domains of
expression of SFRP1 that may serve as cue to establish their
connectivity [15,18,54,55]. In regard to other Pax6 positive
postmitotic populations in the brain, as the ones referred above,
Sfrp1 expression patterns would be consistent with a possible role
of the Pax6-SFRP1 pair in circuit formation [16,19]. However,
although Sfrp1 knock out mice have been generated and are viable,
defects in axonal connectivity have not yet been investigated [16]
and will require attention in the future, especially in relation to
Pax6, as our results indicate.
Besides axon guidance, an additional interesting implication of our
study is raised by the blocking experiments using anti-SFRP1
antibodies. Our data evidenced the secretion of endogenous SFRP1
by NSCs and differentiating primary cortical cells, which is consistent
with the reported Sfrp1 expression patterns in the developing and
adult brain [19,56]. NCS express Pax6 both in vivo and in vitro,w h i c h
suggests possible roles for the coordinated functions of both molecules
in the physiology of NSCs and neural niches.
Methods
Animals
All animal procedures were approved by the National Center
for Biotechnology Animal Care and Use Committee, in compli-
ance with National and European Legislation (ID 080016).
C57BL6 mice were obtained from Harlan Laboratories, Inc.
(Indianapolis, US). Morning of the day of the appearance of the
vaginal plug was defined as embryonic day (E) 0.5.
Antibodies, immunohistochemistry, histology
Mouse embryos were fixed with 4% paraformaldehyde (PFA) in
0.1 M phosphate-buffered saline (PBS; pH 7.4) and cryoprotected
in 30% sucrose in PBS. 10–20 mm horizontal sections were
produced and mounted on Superfrost plus microscope slides
(Fisher Scientific, Pittsburgh, PA). Inmunostaining of tissue
sections and explants, or cell cultures was performed as described
[20] using the following antibodies: rabbit anti-GFP (Molecular
probes, Eugene, OR, 1:500), mouse anti-b-tubulin III (Sigma-
Aldrich, ST Louis, MO, 1:1000), rat anti-Bromodeoxiuridine
(BrdU) (BD Biosciences, San Jose, CA, 1:250), mouse anti-Islet-1/
2 (39.4D5 1:10) developed by T. Jessell and the monoclonal
antibody anti-Nestin (Rat 401, 1:100) developed by S. Hockfield,
were obtained from the Development Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained by
The University of Iowa, Department of Biological Sciences, Iowa
City, IA 52242, rabbit anti-SFRP1 (Abcam, Cambridge UK,
1:500), goat anti-Brn3 (C-13) (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, 1:250), rabbit anti-Caspase3 (Cell Signaling Tech
Inc, Danuers, MA, 1:500), rabbit anti-Pax6 (Covance, Princeton,
NJ, 1:500), mouse anti-MAP1b (Covance, Princeton, NJ, 1:500),
rabbit anti-Fz2 (Abcam, Cambridge, UK, 1:200), mouse anti-
GFAP (Sigma-Aldrich, ST Louis, MO, 1:400), and Alexa Fluor
488-, 594- or 647-conjugated fluorescent secondary antibodies
(Molecular probes, Eugene, OR, 1:500).
Epifluorescece and confocal microscopy
Confocal microscopy was performed with a TCS-SP5 (Leica
Microsystems GmbH, Welzlar, Germany) Laser Scanning System.
Tissue sections of 50 and 20 mm were analyzed by taking 0.2 mm
serial optical sections with the LASAF v2.2.1 software (Leica
Microsystems GmbH, Welzlar, Germany). Fluorescence micros-
copy was performed with a Leica DMRXA and images were
captured with Leica CW4000 FISH Version V1.2 software.
DNA constructs and recombinant proteins
The hairpin sequences targeting Pax6 were: TRCN0000075
377:ICCGGCCTGAAGCAAGAATACAGGTACTCGAGTACC-
TGTATTCTTGCTTCAGGTTTTTG; ITRCN0000075376:ICC-
GGCATGGCAAACAACCTGCCTATCTCGAGATAGGCAG-
GTTGTTTGCCATGTTTTTG;ITRCN0000075375:ICCGGGA-
CGGCATGTATGATAAACTACTCGAGTAGTTTATCATAC-
ATGCCGTCTTTTTG;ITRCN0000075374:ICCGGCCACTTC-
AACAGGACTCATTTCTCGAGAAATGAGTCCTGTTGAAG-
TGGTTTTTG.
Pax6 and green fluorescence protein (GFP) cDNAs were under
the cytomegalovirus enhancer, chicken b-actin promoter, and
rabbit b-globin poly (A) signal (CAG) (cytomegalovirus [CMV] and
beta-actin) promoter. For knock-down experiments, a mixture of
the selected shRNA lentiviral constructs (1 mg/ml) and pCAG-GFP
(1 mg/ml) was used. For testing off-target effects, we co-electropo-
rated a construct driving expression of a silent resistant form of
Pax6 (1 mg/ml; CAG-mutPax6; see Text S1) and shRNA targeting
Pax6 (1 mg/ml) plasmids. Pax6 lentiviral shRNA constructs were
obtained from Sigma-Aldrich Inc. (St. Louis, MO). Purified
recombinant SFRP1 protein was generated as previously de-
scribed [21] and recombinant purified N-Shh (2.5 mg/ml) was a
kind gift from Dr. Sebastian Pons [22].
In utero and ex vivo electroporation
In utero and ex vivo electroporations were performed as described
previously [23]. E13.5 pregnant C57BL6 female mice were
anesthetized by continuous inhalation of Isoflurane (Baxter.
Deerfield, US). The abdomen was opened and the uterine horns
exposed. The DNA solution containing 0.03% fast green in PBS
was injected into one eye of each embryo using a pulled glass
micropipette. The head of each embryo was placed between
tweezer type electrodes (CUY 650 P5 Nepa GENE, Chiba, Japan)
and five square electric pulses (38V, 50 ms) were passed at 1 sec
intervals using an Electro Square Porator ECM 830 (BTX,
Harvard Apparatus, Holliston, MA, USA). The wall and skin of
the abdominal cavity were sutured and the embryos were allowed
to develop normally until E16-P0. For the ex vivo electroporation
the head of the E13.5 embryos were transfer to a dissecting dish
where they were electroporated with the above conditions. Then,
electroporated retinas were dissected and incubated in DMEM-
F12 (Gibco, Invitrogen, Carlsbad, CA) supplemented with N2
(Gibco, Invitrogen, Carlsbad, CA) medium at 37uC, 5% CO2 for
24 hours.
Retinal explants and analysis of axonal growth
Dorsal retinal microexplants were plated on glass coverslips
coated with poly-D-Lys (50 mg/ml; Sigma-Aldrich, Co. St. Louis,
MO) and laminin (10 mg/ml; Invitrogen, Carlsbad, CA) and
grown for 24 hours in DMEM-F12 medium supplemented with
N2 in the presence or absence of SFRP1 (2 ng/ml) or N-Shh
(1 ng/ml). After 24 hours, explants were fixed in 4% PFA at RT
for 30 minutes and immunostained with anti-b-tubulin III and
anti-GFP antibodies. Axonal length was determined in confocal
images employing LaserPix v.4 image software (Bio-Rad). In non-
electroporated explants, axonal length was estimated by counting
the number of b-tubulin III positive axons crossing 600 and
900 mm radius circumferences of a minimum of 100 axons in each
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explants, we measured the length of each individual GFP positive
axon from the edge of the explant up to the distal tip of the growth
cone. Knock-down of Pax6 in RGCs did not interfere with axonal
initiation because the number of total axons per explants was not
significantly different in control and Pax6 shRNA electroporated
retinas (not shown). It was also not affected by treatment with
SFRP1, Netrin1 or Shh. For SFRP1 experiments at least 50 axons
per condition in each independent experiments (n=6) or 60
neurons per condition (n=4) in Shh and Netrin1 experiments. We
chose to specifically study SFRP1 response in dorsal explants
because this population expresses high levels of Pax6 and is
homogeneously composed of contra-laterally projecting axons
facilitating the analysis of SFRP1 response.
Neurosphere culture and nucleofection
Dorsal telencephalons of E13.5 WT embryos were dissected and
cells were dissociated employing trypsin and a flamed-tip, glass
Pasteur pipette. Dissociated cells were cultured in DMEM-F12
supplemented with N2 (Gibco, Invitrogen, Carlsbad, CA),
heparin, recombinant human basic fibroblast growth factor
(FGF-2) (10 ng/ml; R&D Systems, Minneapolis, MN), and
epidermal growth factor (EGF; 10 ng/ml; Gibco, Invitrogen,
Carlsbad, CA). Neurosphere cultures were passage every 3 days by
mechanical dissociation. Dissociated cells were transfected using
the nucleofector (Amaxa Biosystems, Gaithersburg, MD) with 5 mg
of a 1:1 mixture of CAG-GFP and CAG-Pax6 or CAG- empty
vector. Nucleofection efficiency and GFP positive cells were
analyzed by flow cytometer (Coulter Epix XL) and data were
analyzed with the Win MIDI software. Nucleofected neurospheres
were seeded on glass coverslips coated with poly-D-Lys and
cultured in DMEM-F12 supplemented with N2, heparin and 1%
fetal calf serum (FCS). Cells were fixed in 4% PFA at RT for
30 minutes, then immunostained with anti-b-tubulin III and anti-
GFP antibodies. Axonal length was determined with the LaserPix
v.4 image software (Bio-Rad, Richmond, CA) over images taken
with a fluorescence microscopy Leica DMRXA. For analysis of the
effects of Pax6, cells were fixed after 6 or 9 days in culture. To
compare neurons that exit at the same time from the cell cycle,
postmitotic neurons were labeled with a 12 h pulse of Bromo-
deoxiuridine (BrdU, Sigma-Aldrich, ST Louis, MO) (0.5 ng/ml) in
the media and subsequently extensively washed. For blocking the
endogenous SFRP1 activity a mix of anti-SFRP1 antibodies (4 mg/
ml dialyzed in PBS): rabbit anti-SFRP-1 and goat anti-SFRP-1 (H-
90 and C-19; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or
a control IgG (4 mg/ml, dialyzed in PBS; rabbit anti-p-aPAK Ser
199/204; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were
added to the culture media after nucleofection. For stimulation
experiments, SFRP1 was added to the media 24 h after the
nucleofection and the early axonal growth measured 3 days after
the addition of SFRP1.
Primary neurons culture and transfection
Dissociated cells from the dorsal telencephalon of E13.5
embryos were seeded onto 24 well Poly-D-Lys coated plates in
Neurobasal media supplemented with B27 complement (Gibco,
Invitrogen, Carlsbad, CA) and BrdU (0.5 ng/ml) to test
proliferation. 24 h after seeding, cells where co-transfected with
CAG-Pax6 or the empty CAG- vector and CAG-GFP using
lipofectamine 2000 (Invitrogen, Carlsbad, CA) and following
manufacture procedure. Three days after transfection, cells were
fixed with PFA 4%, and immunostained with anti-b-tubulin III
and anti-GFP antibodies to measure their axonal length as
describe next. GFP positive neurons did not incorporate BrdU
demonstrating an effect on posmitotic neurons independent of cell
cycle exit. As mentioned, SFRP1 was added to the media 24 h
after transfection and the axons measured 2 days after the addition
of the protein.
Quantification of axonal length
In neurons differentiated from NSC or primary neurons, we
identified the axon by morphological criteria and the specific
staining of MAP1b, selectively localized to the distal part of axonal
projections [24], but not in neurites. As illustrated in Fig. 1d,
staining with MAP1b allowed us to identify the axon in primary
neurons, while GFP staining reveals transfected cells. In neurons
derived from NSCs after 6 and 9 days of differentiation, a long
projection neurite was always clearly observed (Fig. 1c) and
quantified as an axon. Specific staining with MAP1b demonstrated
that the axon was always the longest neurite projection (99%
Map1b positive projections were the longest neurite in the cell
(.100 cells counted). Accordingly, experiments in which we
measure MAP1b or the morphological identified neurite gave
equivalent results (compared results shown in Fig. 1e and Fig. 2).
We measured the axonal length from the nucleus of the neurons to
the distal end of the axon where the growth cone is localized. We
analyzed a minimum of 50 axons per condition in four
independent experiments (n=4).
Statistical analysis
Quantitative results are expressed as the mean 6 SD. Axonal
length distributions of each population were compared using a
Chi-square test. Differences in gene expression was analyzed were
compared with Student’s two-sample t test. P values are indicated
in figure legends.
Supporting Information
Figure S1 Efficiency of Pax6 overexpression and inhi-
bition. a) Transfection of pCAG-Pax6 in NSCs results in efficient
overexpression of Pax6 proteins in NSC derived neurons. Pax6
proteins are not expressed normally in GFP positive CAG-control
targeted neurons, but are ectopically expressed (yellow) in cells
transfected with CAG-Pax6 plasmid. Bar indicates 20 mm. b)
Fluorescent-activating cell sorting (FACs) analysis demonstrates
more than 20% transfection efficiency. c) Ectopic Pax6 expression
in NSCs does not alter the total number of secondary and primary
neurites per cell. The number of neurites, excluding the axon, was
quantified 9 days after transfection. d) Transfection of shRNA
lentiviral constructs efficiently suppresses the ectopic expression of
Pax6 in CHO cells. CHO cells co-trasfected with CAG-Pax6;
control shRNA and CAG-GFP show expression of Pax6 protein
(red). Pax6 is down-modulated in cells transfected with CAG-Pax6
and shRNAs targeting Pax6. Number of cells .100 (n=3). Bar
indicates 30 mm. Graph represents the proportion of GFP positive
cells expressing Pax6 protein. Data are expressed as the mean 6
SD. (***) p,0.001.
(TIF)
Figure S2 Ectopic expression of Pax6 stimulates axonal
growth in cortical neurons. NSCs were nucleofected with
CAG-empty vector or CAG-Pax6 and co-electroporated with
CAG-GFP. Graph shows the percentage of nucleofected neurons
with respect to their axonal length after 6 days of differentiation.
Results are equivalent to those obtained at 9 days. Over-
expression of Pax6 increments the axonal length compare with
control neurons. Data are expressed as the mean 6 SD. (**)
p,0.01.
(TIF)
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over-expressing neurons but not in the control popula-
tion. Graph represents the population distribution of neurons
with axons longer than 100 mm or more. Data are expressed as the
mean 6 SD. (**) p,0.01; (***) p,0.001.
(TIF)
Figure S4 Knock-down of Pax6 did not affect the
expression of Fz2 receptor. a) Micrographs show confocal
images of GFP positives axons in retina explants that were
electroporated with shRNA control or shRNA targeting Pax6, and
with CAG-GFP. Both populations present low levels of Fz2
expression and a positive dotted pattern of Fz2 staining. GFP
negative mature axons presented a stronger signal. Bar indicates
3 mm. b) Q-PCR detection of the relative expression of the mRNA
of Fz1, Fz3, Fz5, Fz6, Unc5a, Unc5b, Unc5c, Unc5d, Neuropilin1
and PlexinD1 from primary cultured neurons. Expression levels
are relative to GAPDH transcript and normalized to one control
sample (see Text S2). There are no differences in the relative
mRNA expression of these receptors in control and Pax6
transfected cells.
(TIF)
Text S1 cDNA sequence for the silent mutant form of
Pax6 resistant.
(DOCX)
Text S2 Methods for real-time quantitative RT-PCR (Q-
PCR).
(DOCX)
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